Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-24

Clinical Trial Update: A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of EDG-5506 in adult males with Becker muscular dystrophy completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EDG-5506 (EDG-5506)

Snippet

Sponsor: Edgewise Therapeutics, Inc. | Conditions: Becker Muscular Dystrophy | Phase 1 | Status: COMPLETED | Results posted: 2025-06-24